---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-073892"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2022-06-23T23:59:59+00:00"
generated_at: "2026-06-24T23:39:46.904269+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics terminates Cambridge lease and BioNTech sublease without penalty

## Summary
- Lease termination effective June 22, 2022; no termination fees incurred.
- Original lease on ~45,000 sq ft at 75 Sidney Street was set to expire Nov 30, 2026.
- BioNTech sublease on ~18,000 sq ft terminated early; BioNTech enters direct lease with landlord.
- Voyager conveyed certain personal property in the premises to BioNTech via bill of sale.
- Both lease and sublease ended without any penalty; no further rent obligations.

## SEC filing metadata
- accession: 0001104659-22-073892
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2022-06-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465922073892/0001104659-22-073892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465922073892/tm2219269d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-073892
- JSON: https://secwatch.observer/filing/0001104659-22-073892.json
- Plain text: https://secwatch.observer/filing/0001104659-22-073892.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
